Skip to main content
Signal8

Integer Holdings Corp (ITGR)

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Sector: Electromedical & Electrotherapeutic Apparatus

Industry: Medical - Devices

Integer Holdings Corporation logo

Integer Holdings Corporation

NYSE:ITGRHealthcare
-0.02%$126.54
AH Close$126.54+0.00%vs close
Mkt Cap$4.3B
Float33.72M
O/S34M
Inst Own-
SI9.3%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$4.30B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 34.00M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE
CountryUSUS
IPO DateSep 29, 2000
Shares Outstanding34.00M
Float33.72M
Company Overview

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions.

The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Leadership

Payman Khales

Chief Executive Officer, President & Director

Andrew Senn

President of Growth & Innovation

Diron Smith

Executive Vice President & Chief Financial Officer

John Harris

President of Global Operations & Manufacturing Technology

Employees

11K+

Country

US

Sector

Healthcare

Website

integer.net

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$127.00+0.4%
Low $127High $127
Ratings Distribution
BUY
8
HOLD
8
SELL
0
TOTAL16
Insider Trading
InsiderTypeShares
Thor Kirk K profile photoThor Kirk KSale11.8K
Thor Kirk K profile photoThor Kirk KSale19.8K
Senn Andrew profile photoSenn AndrewSale9.4K
Metcalf Milo Stephen II profile photoMetcalf Milo Stephen IIGrant/Award892
Metcalf Milo Stephen II profile photoMetcalf Milo Stephen IIGrant/Award4.5K
Thor Kirk K profile photoThor Kirk KOption Exercise6.1K
Shareholders
-
Institutionalⓘ
(338)
1.0%
Insiderⓘ
(24)
17.5%
5%+ Owners
(3)
-
Unattributed (incl. retail)ⓘ
Insider1.0%
5%+ Beneficial17.5%
Sources: 13F, Form 4, 13D/13GO/S: 34.0M · checked 25 Oct 2026 · market-data provider
Insiders & Institutional Holders
52-Week Range
$62.00$126.83
$126.54(100th percentile)
Volume
Average Daily Volume925.88K
603.13K today vs 925.88K avg(-35%)

30d Avg

925.88K

60d Avg

830.45K

90d Avg

1.11M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...